Top Markets
#1 0G 0G +38.62%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.25%
#3 Useless Coin Useless Coin +34.12%
#4 StonkBroker StonkBroker +31.74%
#5 Arbitrum Arbitrum +31.19%
#6 SAFEcoin SAFEcoin +28.71%
#7 Notcoin Notcoin +19.84%
#8 Pons Pons +18.99%
#9 Full Moon Full Moon +18.20%
#10 Curve DAO Curve DAO +16.10%
Coin of the day
0G 0G
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Hisse Senetlerindeki Sıralama #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Hisse Fiyatı
$4.36
Piyasa Değeri
$457.32M
Değişim (1 gün)
0.69%
Değişim (1 yıl)
289.29%
Ülke
US
Ticaret Relmada Therapeutics, Inc. (RLMD)

Kategori

Healthcare
Relmada Therapeutics, Inc. (RLMD) için kazanç
2026 itibarıyla kazanç TTM: 0
Relmada Therapeutics, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Relmada Therapeutics, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH